Xenon Pharmaceuticals Inc. (XENE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xenon Pharmaceuticals Inc...

    NASDAQ: XENE · Real-Time Price · USD
    39.61
    0.41 (1.05%)
    At close: Oct 03, 2025, 3:59 PM
    39.61
    0.00%
    After-hours: Oct 03, 2025, 04:39 PM EDT

    Xenon Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 142.71M 148.64M 57.24M 175.69M
    Short-Term Investments
    		 484.19M 489.44M 534.85M 376.09M
    Long-Term Investments
    		 127.5M 292.79M 128.68M n/a
    Other Long-Term Assets
    		 7.5M 7.4M 7.75M n/a
    Receivables
    		 1.47M 874K 986K 2.77M
    Inventory
    		 n/a n/a -986K -2.77M
    Other Current Assets
    		 6.89M 6.01M 7.22M n/a
    Total Current Assets
    		 635.26M 644.96M 600.3M 559.02M
    Property-Plant & Equipment
    		 18.22M 18.85M 16.91M 12.52M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 162.88M 319.84M 153.85M 12.99M
    Total Assets
    		 798.14M 964.8M 754.15M 572.01M
    Account Payables
    		 5.07M 8.6M 8.49M 3.82M
    Deferred Revenue
    		 n/a n/a n/a 9.29M
    Short-Term Debt
    		 9.02M n/a n/a n/a
    Other Current Liabilities
    		 -2.62M 347K 7.9M 3.95M
    Total Current Liabilities
    		 35.59M 27.27M 22.7M 14.32M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 7.65M 9.6M 9.95M 7.65M
    Total Liabilities
    		 43.24M 36.88M 32.65M 21.97M
    Total Debt
    		 9.02M 10.9M 10.44M 8.26M
    Book Value
    		 754.9M 927.92M 721.5M 550.03M
    Book Value Per Share
    		 9.69 13.87 11.92 12.61
    Common Stock
    		 1.46B 1.44B 1.07B 783.17M
    Retained Earnings
    		 -899.47M -665.14M -482.75M -357.37M
    Comprehensive Income
    		 -1.61M -77K -3M -990K
    Shareholders Equity
    		 754.9M 927.92M 721.5M 550.03M
    Total Investments
    		 611.69M 782.23M 663.53M 376.09M

    Add to Watchlist